PRIA Logo™
119-s-4987119th Congress

Pharmaceutical Investment Oversight and Accountability Act

Sponsored By: Senator Warren, Elizabeth [D-MA]

Introduced

Summary

Would require the Federal Trade Commission to report annually on how foreign investment affects the U.S. pharmaceutical industry and DNA sequencing capacity. The reports would assess supply chain concentration, impacts on domestic drug and ingredient production, effects on genome sequencing and storage, and the FTC would post an unclassified summary on its website.

Show full summary
  • Would require the FTC, working with the Treasury through the Committee on Foreign Investment in the United States, to deliver an initial report within 1 year and yearly updates to HHS, the FDA Commissioner, and specified congressional committees.
  • Would direct assessments of supply chain concentration and reliance on foreign manufacturing and of how foreign investment affects the U.S. capacity to produce drugs and active and inactive drug ingredients.
  • Would evaluate effects of foreign investment on DNA sequencing and storage technologies and on national capacity to sequence or store DNA.
  • Would require the report to include the number of Committee reviews and investigations in the prior 10 fiscal years related to covered transactions for drug manufacturing or DNA sequencing or storage and a short description of each outcome, including approvals, prohibitions, or approvals subject to mitigation agreements.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Warren, Elizabeth [D-MA]

MA • D

Cosponsors

  • Sen. Scott, Rick [R-FL]

    FL • R

    Sponsored 7/15/2026

  • Sen. Gillibrand, Kirsten E. [D-NY]

    NY • D

    Sponsored 7/15/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation